Results

eNauka >  Results >  Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients
Title: Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients
Authors: Coles, Alasdair; Brinar, Vesna; Arnold, Douglas L; Cohen, Jeffrey; Confavreux, Christian; Fox, Edward; Hartung, Hans; Havrdova, Eva; Selmaj, Krzysztof; Weiner, Howard;
Giovannoni, Gavin; Stojanovic, Miroslav; Lake, Stephen; Margolin, David; Panzara, Michael; Compston, Alastair;
Issue Date: 2012
Publication: NEUROLOGY
ISSN: 0028-3878 Neurology Search Idenfier
Type: Conference Paper
Collation: vol. 78
WoS-ID: 000303204800382
URI: https://enauka.gov.rs/handle/123456789/819802
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

5
WEB OF SCIENCETM

Find the DOI

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.